Third, because we used retrospective cohort data, we were unable to incorporate certain potential covariates that influence breast cancer mortality, such as education level, household size, family history of breast cancer, health literacy, hormone receptor status, and tumor characteristics, including triple-negative status and other prognostic indicators (e.g., tumor grade, HER2 status). The gene discussed is ERBB2; the disease is breast cancer.